Navigation Links
Testosterone levels could serve as a marker for determining risk of SIDS

A recent study conducted on the Sudden Infant Death Syndrome (SIDS) has found out that nearly all cases are associated with an increase in testosterone levels. Testosterone is a male sex hormone. //The levels are considerably higher in infants who have died suddenly from SIDS than in infants who have died suddenly from other causes.

Researchers from the University of Washington compared hormone levels in blood collected from 169 infants who had died of SIDS and 42 who died of other causes. A significant elevation of the male hormone levels were found in the cases studied. In contrast, levels of estradiol, an estrogen-type hormone, did not differ significantly between SIDS victims and the control group.

SIDS is the sudden and unexplained death of an infant. It is the leading cause of death among infants who are 1 month to 1 year old. SIDS should be diagnosed only when all other possible causes of death have been ruled out by a detailed evaluation of the medical history. There is no specific symptom to diagnose the condition

Previous studies have already hinted the possibility of a link between SIDS and sex hormone levels, such as the correlation between the rise in sex hormone levels and the age range of risk for SIDS. Moreover, testosterone levels have also been implicated in a number of sleep disorders associated with breathing difficulties in adults. Any alteration in the levels of the sex hormones (testosterone and estrogen) can affect the nerve structure and function in older and younger male and female animals. More importantly, any increase in these levels following birth can result in a compromise involving the nervous system in otherwise-normal infants.

In conclusion, further research is needed to determine whether testosterone is abnormal in living infants at risk for SIDS and to determine the value of monitoring testosterone or related hormones to identify those infants at increased risk of SIDS.
'"/>




Page: 1

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. Testosterone Therapy can improve sexual function in postmenopausal women
8. Fatherhood Found To Tame Men by Reducing Testosterone Levels
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
Breaking Medicine Technology:Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6QLT Announces Second Quarter Results for 2009 52895 1QLT Announces Second Quarter Results for 2009 52895 2QLT Announces Second Quarter Results for 2009 52895 3QLT Announces Second Quarter Results for 2009 52895 4QLT Announces Second Quarter Results for 2009 52895 5QLT Announces Second Quarter Results for 2009 52895 6QLT Announces Second Quarter Results for 2009 52895 7QLT Announces Second Quarter Results for 2009 52895 8QLT Announces Second Quarter Results for 2009 52895 9QLT Announces Second Quarter Results for 2009 52895 10QLT Announces Second Quarter Results for 2009 52895 11QLT Announces Second Quarter Results for 2009 52895 12QLT Announces Second Quarter Results for 2009 52895 13QLT Announces Second Quarter Results for 2009 52895 14QLT Announces Second Quarter Results for 2009 52895 15QLT Announces Second Quarter Results for 2009 52895 16QLT Announces Second Quarter Results for 2009 52895 17NeoGenomics Reports Second Quarter 2009 Results 13224 1NeoGenomics Reports Second Quarter 2009 Results 13224 2NeoGenomics Reports Second Quarter 2009 Results 13224 3NeoGenomics Reports Second Quarter 2009 Results 13224 4NeoGenomics Reports Second Quarter 2009 Results 13224 5NeoGenomics Reports Second Quarter 2009 Results 13224 6NeoGenomics Reports Second Quarter 2009 Results 13224 7NeoGenomics Reports Second Quarter 2009 Results 13224 8NeoGenomics Reports Second Quarter 2009 Results 13224 9GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite 52890 1GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite 52890 2